lycorine has been researched along with dihydrolycorine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andolfi, A; Bruyère, C; Cimmino, A; Dubois, J; Evidente, A; Gras, T; Kiss, R; Kornienko, A; Lamoral-Theys, D; Le Calvé, B; Mathieu, V; Mégalizzi, V; Van Goietsenoven, G; Wauthoz, N | 1 |
| Nair, JJ; van Staden, J | 1 |
1 review(s) available for lycorine and dihydrolycorine
| Article | Year |
|---|---|
Antiprotozoal alkaloid principles of the plant family Amaryllidaceae.
Topics: Amaryllidaceae; Amaryllidaceae Alkaloids; Antiprotozoal Agents; Diterpenes; Drug Evaluation, Preclinical; Humans; Isoquinolines; Molecular Structure; Phytochemicals; Plant Extracts; Structure-Activity Relationship; Trypanosoma brucei brucei | 2019 |
1 other study(ies) available for lycorine and dihydrolycorine
| Article | Year |
|---|---|
Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
Topics: Actins; Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Cytoskeleton; Drug Resistance, Neoplasm; Female; Humans; Inhibitory Concentration 50; Maximum Tolerated Dose; Melanoma; Mice; Phenanthridines; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2009 |